Alignment Healthcare, Inc. (ALHC)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 500M 1B 1.5B Q1 '20: 224.6M Q2 '20: 244.3M Q3 '20: 247.9M Q4 '20: 242.4M Q1 '21: 267.1M Q2 '21: 309M Q3 '21: 293.5M Q4 '21: 298.3M Q1 '22: 345.5M Q2 '22: 366.5M Q3 '22: 360.3M Q4 '22: 361.8M Q1 '23: 439.2M Q2 '23: 462.4M Q3 '23: 456.7M Q4 '23: 465.4M Q1 '24: 628.6M Q2 '24: 681.3M Q3 '24: 692.4M Q4 '24: 701.2M Q1 '25: 926.9M Q2 '25: 1B Q3 '25: 993.7M Q4 '25: 1B Q1 '26: 1.2B Q2 '26: 1.3B Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Gross Profit Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income Quarterly

-60M -40M -20M 0 20M 40M 60M Q1 '20: -5.1M Q2 '20: 12.6M Q3 '20: 15.1M Q4 '20: -27.8M Q1 '21: -52.7M Q2 '21: -40.5M Q3 '21: -41.5M Q4 '21: -43.5M Q1 '22: -36.5M Q2 '22: -6.6M Q3 '22: -33.4M Q4 '22: -52.1M Q1 '23: -32.5M Q2 '23: -23.7M Q3 '23: -29.8M Q4 '23: -41.9M Q1 '24: -41.1M Q2 '24: -18.4M Q3 '24: -19.5M Q4 '24: -22.5M Q1 '25: -5.4M Q2 '25: 22.7M Q3 '25: 7.7M Q4 '25: -10.3M Q1 '26: 15.5M Q2 '26: 42.1M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Net Income Quarterly

-60M -40M -20M 0 20M 40M 60M Q1 '20: -10.1M Q2 '20: 8.4M Q3 '20: 10.8M Q4 '20: -32.1M Q1 '21: -56.9M Q2 '21: -44.8M Q3 '21: -45.8M Q4 '21: -47.8M Q1 '22: -40.8M Q2 '22: -11.6M Q3 '22: -40.2M Q4 '22: -56.9M Q1 '23: -37.3M Q2 '23: -28.5M Q3 '23: -35M Q4 '23: -47.2M Q1 '24: -46.5M Q2 '24: -24M Q3 '24: -26.4M Q4 '24: -31.1M Q1 '25: -9.1M Q2 '25: 15.7M Q3 '25: 3.7M Q4 '25: -11M Q1 '26: 11.4M Q2 '26: 36.6M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Cost of Revenue Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Quarterly

-50M 0 50M 100M 150M Q1 '20: -21.8M Q2 '20: 13.5M Q3 '20: 26M Q4 '20: -10.1M Q1 '21: -38.1M Q2 '21: -23.4M Q3 '21: 12.9M Q4 '21: -30.1M Q1 '22: -11.6M Q2 '22: 10.4M Q3 '22: 105.1M Q1 '23: 85.1M Q2 '23: 37.2M Q3 '23: 6M Q1 '24: -6.2M Q2 '24: 23.5M Q3 '24: 26.2M Q4 '24: -8.7M Q1 '25: 16.6M Q2 '25: 29.1M Q3 '25: 144.6M Q1 '26: 128.7M Q2 '26: -17.3M Q2 '20 Q1 '21 Q4 '21 Q3 '22 Q3 '23 Q3 '24 Q2 '25 Q2 '26

Free Cash Flow Quarterly

-50M 0 50M 100M 150M Q1 '23: 77.8M Q2 '23: 28.6M Q3 '23: -3.6M Q1 '24: -17.4M Q2 '24: 11.8M Q3 '24: 16.9M Q4 '24: -18M Q1 '25: 8.4M Q2 '25: 21.1M Q3 '25: 139.1M Q1 '26: 121.3M Q2 '26: -27.5M Q2 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 80M 160M 240M Q1 '20: 0 Q1 '21: 12.6M Q1 '22: 16.2M Q3 '22: 187.3M Q1 '23: 183.1M Q2 '23: 186M Q3 '23: 187.3M Q1 '24: 189M Q2 '24: 190.9M Q3 '24: 191.4M Q1 '25: 193.6M Q2 '25: 209.5M Q3 '25: 208.9M Q1 '26: 213.1M Q2 '26: 215M Q1 '20 Q1 '22 Q1 '23 Q3 '23 Q2 '24 Q1 '25 Q3 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-1.05 -0.70 -0.35 0.00 0.35 0.70 1.05 Q4 '20: -0.16 Q1 '23: -0.80 Q2 '23: -0.89 Q3 '23: -0.86 Q4 '23: -0.79 Q1 '24: -0.84 Q2 '24: -0.82 Q3 '24: -0.77 Q4 '24: -0.68 Q1 '25: -0.48 Q2 '25: -0.28 Q3 '25: -0.12 Q4 '25: -0.00 Q1 '26: 0.10 Q2 '26: 0.20 Q4 '20 Q2 '23 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.